/ 26 Shares
14-Jul-2025 - 16-Jul-2025
₹ 540 - ₹ 570
₹ 14820.00
26
59,575,319
Face Value - ₹ 2/- Per Share
Listing at NSE, BSE
799,839 Application Required in Retail for 1 Time.
Registrar : KFin Technologies Limited
| Category | % | Shares/Amount |
|---|---|---|
| QIB | 50% | 29,708,332 Shares Rs. 1693.37 CR |
| HNI 1 | 5% | 2,970,834 Shares Rs. 169.34 CR @ 8162 FORM 1X |
| HNI 2 | 10% | 5,941,666 Shares Rs. 338.68 CR @ 16323 FORM 1X |
| Retail | 35% | 20,795,834 Shares Rs. 1185.36 CR @ 799840 FORM 1X |
| Employee | 0% | 158,563 Shares RS.8.25 CR |
| Retail (Upto 2 Lakh) | HNI (2 Lakh to 10 Lakh) | HNI (Above 10 Lakh) |
|---|---|---|
| 799840 FORM 1X | 8162 FORM 1X | 16323 FORM 1X |
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Upto 2 Lakh) | 1 | 26 | ₹ 14,820 |
| Retail (Upto 2 Lakh) | 13 | 338 | ₹ 192,660 |
| S-HNI (2 Lakh to 10 Lakh) | 14 | 364 | ₹ 207,480 |
| S-HNI (2 Lakh to 10 Lakh) | 67 | 1742 | ₹ 992,940 |
| B-HNI (Above 10 Lakh) | 68 | 1768 | ₹ 1,007,760 |
16-Jul-2025 17:40
| Category | Book Size | Subscription | No. of Times |
|---|---|---|---|
| QIB | 11,883,333 ₹ 677.35 Cr. | 957,762,312 ₹ 54592.45 Cr. | 80.60x |
| HNI (<10 LAKH) | 2,970,834 ₹ 169.34 Cr. | 37,278,098 ₹ 2124.85 Cr. | 12.55x |
| HNI2 (>10 LAKH) | 5,941,666 ₹ 338.67 Cr. | 145,244,216 ₹ 8278.92 Cr. | 24.45x |
| RETAIL | 20,795,834 ₹ 1185.36 Cr. | 49,478,338 ₹ 2820.27 Cr. | 2.38x |
| EMP | 158,653 ₹ 9.04 Cr. | 405,782 ₹ 23.13 Cr. | 2.56x |
| Total | 41,750,320 | 1,190,168,746 | 28.51x |
| Category | Book Size | Subscription | No. of Times |
|---|---|---|---|
| QIB | 11,883,333 ₹ 677.35 Cr. | 957,762,312 ₹ 54592.45 Cr. | 80.60x |
| HNI (<10 LAKH) | 2,970,834 ₹ 169.34 Cr. | 37,278,098 ₹ 2124.85 Cr. | 12.55x |
| HNI2 (>10 LAKH) | 5,941,666 ₹ 338.67 Cr. | 145,244,216 ₹ 8278.92 Cr. | 24.45x |
| RETAIL | 20,795,834 ₹ 1185.36 Cr. | 49,478,338 ₹ 2820.27 Cr. | 2.38x |
| EMP | 158,653 ₹ 9.04 Cr. | 405,782 ₹ 23.13 Cr. | 2.56x |
| Total | 41,750,320 | 1,190,168,746 | 28.51x |
*Excluding Anchor
Total No. of Application Approx : ~1404309 (1.76 Appwise)
Disclaimer: The above-mentioned information / data are sourced from the websites of National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) and are subject to change on real time basis. For updated information / data you can visit their respective website. The information / data provided herein above are for information purpose only and provided "AS IS" and "AS AVAILABLE" basis and without warranty, express or implied. We do not guarantee or warrant the accuracy, adequacy or completeness of the information received through the said websites. “We” hold not responsibility of any kind as regard to any discrepancies, errors, omissions, losses or damages. “We” including its affiliates and any of its officers, directors, personnel and employees, shall not liable for any loss, damage of any nature, including but not limited to direct, indirect, punitive, special, exemplary, consequential, as also any loss of profit in any way arising from the use of information / data received through the said websites. The recipient alone shall be fully responsible / are liable for any decision taken on the basis of such information / data. All recipients should before acting upon the said information make their own investigation, seek appropriate professional advice.
Incorporated in 2006, Anthem Biosciences Limited is an innovation-driven and technology-focused Contract Research, Development, and Manufacturing Organization (“CRDMO”) with fully integrated operations encompassing drug discovery, development, and manufacturing processes.
The company serves diverse customers, including innovative, emerging biotech firms and large pharmaceutical companies on a global scale.
The company manufactures specialized fermentation-based APIs, including probiotics, enzymes, peptides, nutritional actives, vitamin analogues, and biosimilars.
For the six months concluding on September 30, 2024, the company engaged in the manufacture of active pharmaceutical ingredients (API) and intermediates for ten commercial molecules, all of which have been supported since their discovery.
As of September 30 2024, the company had 196 projects: 170 discovery projects (284 synthesized molecules), 132 early phase projects, 16 late phase projects (10 late phase molecules), and 13 commercial manufacturing projects (API and intermediates for 10 commercialized molecules).
As of September 30 and March 31, 2024, the company had over 425 and 550 customers in our CRDMO and specialty ingredients businesses, spanning more than 44 countries, including the U.S., Europe, and Japan.
As of March 31, 2024, the company served over 150 customers, from small biotech to large pharmaceutical companies.
As of September 30, 2024, the company holds one patent in India, seven overseas, and has 24 pending global patent applications, including process patents for glycolipid synthesis and GLP-1 analogues.
As of September 30 2024, the company's team consists of 600 employees, including medicinal chemists, microbiologists, molecular biologists, biochemists, experts in various in-vivo non-clinical research and chemical engineers.
Competitive Strength
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 2,807.58 | 2,398.11 | 2,014.46 |
| Revenue | 1,930.29 | 1,483.07 | 1,133.99 |
| Profit After Tax | 451.26 | 367.31 | 385.19 |
| EBITDA | 683.78 | 519.96 | 446.05 |
| Net Worth | 2,409.86 | 1,924.66 | 1,740.67 |
| Reserves and Surplus | 2,298.05 | 1,815.39 | 1,628.88 |
| Total Borrowing | 108.95 | 232.53 | 125.06 |
| Amount in ? Crore | |||
Once you create your account, Login to Us.
Under IPO Section, you will be able to see a list of Ongoing IPOs, where you can click on apply button.
Add quantity of shares to apply – Maximum 3 bids are allowed (For retail category – max amount Rs.2,00,000/-).
Enter your UPI ID and you will receive mandate on your UPI App.
Once you accept the mandate, Application is submitted successful.
How to Apply for IPOs on Easy Investing
Step 01 : Once you create your account, Login to your acount.
Step 02 : Under IPO Section, you will be able to see a list of Ongoing IPOs, where you can click on apply button.
Step 03 : Add quantity of shares to apply – Maximum 3 bids are allowed (For retail category – max amount Rs.2,00,000/-).
Step 04 : Enter your UPI ID and you will receive mandate on your UPI App.
Step 05 : Once you accept the mandate, Application is submitted successful.
